Skip to main navigation
menu
About
Back to main
Overview
Ionis: A Force for Life
Executive & Leadership Team
Board of Directors
Akcea Therapeuitics
Ionis Innovation
Back to main
Overview
Technology
Pipeline
InnovatIONS Podcast
Ion-ARPA Initiative
Grants & Sponsorships
Patients
Back to main
Overview
Patients
Patient Resources
Patient Experiences
Clinical Trials
Our Medicines
Investors & media
Back to main
Overview
Newsroom
Back to main
Investors & Media
Press Releases
Company Statements
InBriefs
Media Center
Events
Stock Information
Back to main
Investors & Media
Stock Quote & Chart
Analyst Coverage
Ownership Profile
Financials
Back to main
Investors & Media
SEC Filings
Annual Reports
Governance
Back to main
Investors & Media
Governance Documents
Committee Composition
RSU Holdings Guidelines
Investor Resources
Back to main
Investors & Media
Investor FAQs
Contact Us
Careers
Back to main
Overview
Our Culture
Working at Ionis
Post Doctoral Program
Intern Program
Follow Us
twitter-grey
About
Ionis: A Force for Life
Executive & Leadership Team
Board of Directors
Akcea Therapeuitics
Ionis Innovation
Technology
Pipeline
IonnovatIONS Podcast
Ion-ARPA Initiative
Grants & Sponsorships
Patients
Patients
Patient Resources
Patient Experiences
Clinical Trials
Medicines
Investors & media
Overview
Newsroom
Press Releases
Company Statements
InBriefs
Media Center
Stock Information
Stock Quote & Chart
Analyst Coverage
Ownership Profile
Financials
SEC Filings
Annual Reports
Governance
Governance Documents
Committee Composition
Investor Resources
Investor FAQs
Settlement Information
Contact Us
Events
Events
Careers
Our Culture
Working at Ionis
Post Doctoral Program
Intern Program
Follow Us
twitter-grey
Investors & Media
Overview
Newsroom
Events
Stock Information
Financials
Governance
Investor Resources
Investor Email alerts
Investor contact
760-603-2331
Email »
Media contact
760-603-4679
Email »
Contact Information
Contact Information
Investor contact
760-603-2331
Email »
Media contact
760-603-4679
Email »